skip to main content
ukmla 2026

Phobic Anxiety Disorders

Persistent, irrational fear and avoidance of specific objects, situations, or social interactions, causing significant distress or functional impairment — includes specific phobias, social anxiety disorder, and agoraphobia

Psychiatrycommonchronic
On this page
Condition details
Psychiatry
common
6 min read
reviewed 2026-04-05
practice ukmla questions →

About This Page

This is a clinician-written, evidence-based summary aligned to the 2026 MLA Content Map. It is intended for medical students and junior doctors preparing for the UKMLA. Always cross-reference with NICE guidance, local protocols, and clinical judgement.

Key points

  • Three main types: specific phobias (most common), social anxiety disorder (SAD), and agoraphobia
  • Core feature: marked, disproportionate fear + avoidance of a specific stimulus causing significant functional impairment
  • Social anxiety disorder (NICE CG159): persistent fear of social/performance situations due to fear of scrutiny and humiliation
  • First-line for SAD: individual CBT specifically developed for SAD. If CBT declined/unavailable → SSRI (escitalopram or sertraline)
  • Specific phobias: graded exposure therapy is first-line — highly effective. Pharmacotherapy rarely indicated
  • Agoraphobia: usually comorbid with panic disorder — CBT with graded exposure and systematic desensitisation

Overview

Phobic anxiety disorders are characterised by persistent, excessive, and irrational fear of specific objects, situations, or social interactions, leading to avoidance behaviour that causes significant distress or functional impairment. They are subdivided into: specific phobias (isolated fear of a particular object or situation, e.g. spiders, heights, blood, needles); social anxiety disorder (fear of social or performance situations due to concern about embarrassment or negative evaluation); and agoraphobia (fear and avoidance of situations where escape may be difficult, often associated with panic disorder). The key cognitive feature is an overestimation of threat and underestimation of coping ability.

Epidemiology

Phobic disorders are among the most common mental health conditions. Specific phobias have a lifetime prevalence of ~10% and often begin in childhood. Social anxiety disorder affects approximately 3–7% of the population, with onset typically in adolescence. Agoraphobia occurs in ~2% of the population, usually developing in early adulthood, often following panic attacks. All are more common in women (except social anxiety, which shows a more equal sex ratio). Risk factors include family history, negative early experiences, behavioural inhibition temperament, and adverse social experiences (bullying, humiliation).

Clinical Features

Symptoms
Intense, irrational fear when exposed to (or anticipating) the phobic stimulus — out of proportion to actual danger
Anticipatory anxiety: dread and worry before exposure to the feared situation
Avoidance behaviour — reorganising life to avoid the stimulus, often restricting daily activities
SAD: fear of being judged, embarrassed, or humiliated in social/performance situations
SAD: difficulty speaking, eating, or writing in front of others; avoidance of meetings, parties, phone calls
Agoraphobia: fear of crowds, public transport, open/enclosed spaces, being alone outside
Physical anxiety symptoms on exposure: palpitations, sweating, tremor, nausea, blushing (especially SAD)
Blood-injection-injury phobia: vasovagal response (bradycardia, hypotension, syncope) — unique among phobias
Signs
Visible anxiety on exposure: tremor, sweating, blushing, tachycardia
Avoidance or freezing when confronted with phobic stimulus
Normal mental state examination when phobic stimulus absent
Vasovagal syncope with blood-injection-injury phobia

Investigations

First-line
Clinical diagnosisBased on history: persistent fear + avoidance + functional impairment. No specific investigations required
SPIN or LSAS (SAD)Social Phobia Inventory or Liebowitz Social Anxiety Scale — validated screening and severity measures
Second-line
Screen for comorbiditiesDepression (PHQ-9), GAD (GAD-7), substance misuse, other anxiety disorders — high comorbidity rates
Specialist
Specialist assessmentIf treatment-resistant, complex comorbidity, or diagnostic uncertainty (e.g. differentiation from avoidant personality disorder)
1
Specific phobias
  • Graded exposure therapy (systematic desensitisation): first-line and highly effective
  • Brief CBT-based exposure programmes (as few as 1–5 sessions) can be curative
  • Pharmacotherapy rarely needed — no strong evidence for routine drug treatment
  • Blood-injection-injury phobia: applied tension technique (tense muscles to prevent vasovagal response)
2
Social anxiety disorder — NICE CG159
  • First-line: individual CBT specifically developed for SAD (Clark and Wells or Heimberg model) — 14 sessions
  • If CBT declined/unavailable: SSRI (escitalopram or sertraline first-line)
  • Start SSRI at low dose and titrate. Review at 6–8 weeks
  • Do NOT offer combined CBT + SSRI as initial treatment — offer sequentially
  • Do NOT offer benzodiazepines, anticonvulsants, or antipsychotics (NICE)
3
Agoraphobia
  • CBT with graded exposure: systematic desensitisation to feared situations
  • If comorbid panic disorder: treat panic disorder first (NICE CG113)
  • SSRI if psychological therapy alone insufficient

Complications

  • Social isolation: Particularly with SAD and agoraphobia — can become housebound
  • Depression: High comorbidity (up to 70% lifetime). Screen regularly
  • Substance misuse: Alcohol commonly used as a social lubricant in SAD
  • Occupational impairment: SAD causes significant career limitation — avoidance of meetings, presentations, networking
  • Healthcare avoidance: Blood-injection-injury phobia can lead to avoidance of medical care, blood tests, and vaccinations
UKMLA Exam Tips
  • 1SAD is NOT shyness — it causes significant functional impairment. Key fear: negative evaluation by others
  • 2Blood-injection-injury phobia is unique: VASOVAGAL response (bradycardia + syncope). All other phobias → tachycardia
  • 3Applied tension technique (tense arm/leg muscles) is specific treatment for blood-injury phobia — prevents fainting
  • 4Graded exposure is the gold-standard treatment for specific phobias — can be curative in a few sessions
  • 5SAD CBT should be specifically developed for social anxiety (Clark and Wells model) — generic CBT is less effective
  • 6Agoraphobia without panic = fear of being in places where escape is difficult; agoraphobia WITH panic is more common

Put your reading into practice

Topic-specific question practice is not linked for this article yet.

Choose UKMLA questions from the existing bank. General exam practice covers your selected topics; it is not filtered to this article. Your usual question-bank access applies.

Choose UKMLA practice

After your session, return to this section to revisit the reading and choose your next review.

Verified Sources & References

NICE CG159 — Social anxiety disorder
NICE CG113 — GAD and panic disorder
Your learning path

Save your place and choose what comes next

Psychiatry · Article 4 of 25